Back to Clinical Trials

Clinical Trials: Psychiatry & Mental Health


Source: Servier
The purpose of this study is to assess the efficacy and safety of S47445 versus placebo as adjunctive treatment of Major Depressive Disorder in patients with an inadequate response to antidepressant therapy. Read More
Last Updated: 14 Jun 2016
Source: University of Ulm
The purpose of the study is to evaluate the efficacy of the group-based intervention 'Honest Open Proud' among adolescents with mental illness. Read More
Last Updated: 14 May 2016
Source: Sunovion
This is an open-label continuation study designed to monitor the safety, tolerability and effectiveness of lurasidone in subjects who have completed participation in a lurasidone extension study (NCT00868959 and NCT01566162) and who may benefit from continued treatment with lurasidone. Read More
Last Updated: 28 Sep 2016
Source: Sha’ar Menashe Mental Health Center
Online consulatations through videoconference in the field of psychiatry given to general practitioners will reduce costs of medical treatment and improve service. Read More
Last Updated: 27 Jan 2009
Source: Technische Universität Dresden
Quality of mental health services provision for adults with intellectual disability and comorbid mental disorder is considered inadequate and therefore in need of further improvement. However, empirical findings on this topic are rather scarce. The MEMENTA-study therefore aims to compare mild and moderate intellectual disabled adults with a comorbid mental disorder to mild and moderate intellectual disabled adults who do not have a comorbid mental disorder ... Read More
Last Updated: 09 Feb 2015
Source: Central Institute of Mental Health, Mannheim
The primary objective is to directly compare the efficacy of acamprosate, naltrexone and placebo for relapse prevention in alcoholics. Read More
Last Updated: 25 Jun 2008
Source: Central Institute of Mental Health, Mannheim
Schizophrenia is a heterogeneous mental disorder that affects one percent of the world's population. Current antipsychotics are only partially effective, and their use is often associated with serious side effects. Cannabidiol is a natural counterpart of the psychoactive component of marijuana, delta-9-tetrahydrocannabinol. While cannabidiol has no psychotomimetic or addictive properties, it indirectly affects endogenous cannabinoid signalling by impairing ... Read More
Last Updated: 29 Sep 2016
Source: University of Sao Paulo General Hospital
The purpose of this project is to compare the effectiveness between face-to-face consultations and consultations via videoconferencing among patients treated in the Institute of Psychiatry (IPq). Read More
Last Updated: 20 May 2015
Source: Charite University, Berlin, Germany
The purpose of this study is to determine if the use of pedometers can help depressive inpatients in psychiatric clinics to increase their level of physical activity. Therefore patients are given a pedometer and instructions how to raise their level of daily steps. Intervention group is compared with a control group that is receiving treatment-as-usual. The intervention is hypothesized to increase number of daily steps and have positive effects on mood, ... Read More
Last Updated: 29 Sep 2016
Source: Central Institute of Mental Health, Mannheim
We aim to compare the augmentation of clozapine with ziprasidone or risperidone in a randomized, prospective manner. Read More
Last Updated: 01 Jun 2008
Source: Sunovion
Lurasidone HCI is a compound that is a candidate for the treatment of bipolar I depression. This clinical study is designed to test the hypothesis that Lurasidone in combination with either Lithium or Divalproex is effective among patients with bipolar I depression. Read More
Last Updated: 30 Oct 2013
Source: Sunovion
Lurasidone HCl is a compound developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is more efficacious than placebo. The study will also evaluate the safety and tolerability of lurasidone as compared to placebo. Read More
Last Updated: 18 May 2015
Source: Central Institute of Mental Health, Mannheim
The purpose of this study is to investigate whether naltrexone reduces the intensity and duration of flashbacks and dissociative states in patients with borderline personality disorder. Read More
Last Updated: 13 Apr 2008
Source: Central Institute of Mental Health, Mannheim
Current antipsychotic treatments of schizophrenia are only partially effective, and their use is often associated with serious side effects. Cannabidiol is a natural counterpart of the psychoactive component of marijuana, delta-9- tetrahydrocannabinol and has no psychotomimetic or addictive properties. In a controlled clinical trial of cannabidiol versus amisulpride in acute paranoid schizophrenia we showed a statistically significant clinical improvement in ... Read More
Last Updated: 23 Oct 2016
Source: Sunovion
This clinical study is designed to test the hypothesis that lurasidone is effective, tolerable, and safe for the treatment of patients with bipolar I depression Read More
Last Updated: 14 Mar 2016
Source: Centre for Addiction and Mental Health
Among youth, the prevalence of mental health and addiction (MHA) disorders is roughly 20%, yet youth are challenged to access services in a timely fashion. To address MHA system gaps, this study will test the benefits of an Integrated Collaborative Care Team (ICCT) model for at-risk youth with MHA challenges. In partnership with community agencies, adolescent psychiatry hospital departments, and family health teams, investigators have developed an innovative ... Read More
Last Updated: 18 Aug 2016
Source: UMC Utrecht
Schizophrenia is a chronic psychiatric illness with periods of remission and relapse. Patients vary in the frequency and severity of relapse, time until relapse and time in remission. Discontinuation of antipsychotic medication is by far the most important reason for relapse. A possible method to optimize medication adherence is to treat patients with long-term, depot medication rather than oral medication. However, despite its apparent "common sense" this ... Read More
Last Updated: 02 Nov 2016
Source: Pearson/Clinical Assessment
Innerview can address some of the challenges of integrating mental health and primary care by accurately and reliably collecting mental health evidence and activities directly from patients, and then organizing and automating that evidence and activity into reports for providers and care teams that support diagnosis, treatment planning and monitoring of the mental health issues within a practice population. Read More
Last Updated: 20 Sep 2015
Source: Johns Hopkins University
This study will determine the effectiveness of a peer support system in increasing physical activity and effecting health behavior change in people with serious mental illnesses. Read More
Last Updated: 22 Apr 2014
Source: Sunovion
Efficacy and Safety study of Lurasidone in pediatric patients. Read More
Last Updated: 06 Jan 2016
Page 1 of 50